Cancer Drug Development

Drug Development is the lengthy procedure because it has ability new drug must be identified and assessed in preclinical and clinical trials. Drug development medication can happen some different ways. If scientist identify new drug by examine numerous compounds in a laboratory procedure for effective ways, like killing or destroying cancerous cells. Cancer drug development is to target DNA or protein. Currently researchers are looking for whole new set of targets. Development of anti-cancer drug is evolving a step towards the invention of novel therapeutics.

Current concept of understanding the kind of cancer invent to conceptual drug design, in which new substance is developed to target a specific disease procedure. At a time, factual medication are found to be having an effectual effect against a various type of cancerous cells. New discovery lead to alteration in designs how medication reach cancerous cells present among the body, thus leading to the capacity to develop a substance. At starting procedure is referred to target and lead identification, validation, and optimization.


  • Tumour Targeting Strategies
  • Hormonal & Biological Agents
  • Cancer Drug Targets
  • Anti-cancer drugs

Related Conference of Cancer Drug Development

June 17-18, 2026

15th World Congress on Chromatography

Paris, France
August 11-12, 2026

5th World Congress on Plasma Chemistry and Plasma Processing

Amsterdam, Netherlands
September 14-15, 2026

22nd European Organic Chemistry Congress

Rome, Italy
September 21-22, 2026

16th International Chemistry Congress

Barcelona, Spain
November 26-27, 2026

6th International Conference on Petrochemistry and Natural Gas

Amsterdam, Netherlands

Cancer Drug Development Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in